Paper Details

Paper Title

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.

Paper Journal Title

Leuk Res

Paper Citation Count

Paper Publication Year

2009

Bio Mention

CML, chronic myeloid leukemia, imatinib, patients

Mesh Descriptor

Paper Details

Column Actions

Datasets